Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) announces, further to its press release dated June 20, 2017, that the Company and BioNeva Innovations of Henderson LLC (“BioNeva”) have jointly submitted a Medical Marijuana Establishment Certificate (the “Nevada Permit”) transfer application (the “Transfer Application”) to the City of Henderson, Nevada , pursuant to which officials from the City of Henderson will consider the transfer of the Nevada Permit from BioNeva to the Company. The Transfer Application includes the requisite documents for such application, including architectural blueprints prepared by a U.S. architecture company for Maple Leaf’s proposed cannabis production site in the City (the “Nevada Site”).
A staff review panel at the City of Henderson (the “Staff Panel”) will review and comment on the Transfer Application, including making suggested changes to the proposed design for the Nevada Site. The review is expected to take place between now and the early part of August when the City Council for the City of Henderson (the “Council”) plans to meet and consider cannabis permit matters. The Company understands that it and BioNeva will have sufficient time to make any suggested changes from the Staff Panel before the Transfer Application is presented to the Council for approval. Once approved by the Council, the Company expects to commence ordering materials and securing construction contracts for development on the Nevada Site. The Company still expects to finish construction of the Nevada Site by the end of 2017.
The Company retains Big Reach Media, Inc. as its Investors Relations Advisor
The Company also announces that it has entered into an investor relations agreement (the “Investor Relations Agreement”) with Big Reach Media, Inc. (“Big Reach”) whereby Big Reach will provide certain services to Maple Leaf that may be considered investor relations and promotional activities on behalf of Maple Leaf which require disclosure in this press release pursuant to the policies of TSX Venture Exchange (the “TSXV”).
Subject to the approval of the TSX Venture Exchange (the “TSXV“), the terms of the Investor Relations Agreement provide that the Company will pay Big Reach a monthly fee of $5,000. The term of the Investor Relations Agreement commences August 1, 2017 and is for an initial term of 6 months. At the end of the initial term, Maple Leaf and Big Reach may agree to extend the engagement on a month to month basis for a fee of $5,000 per month.  
For further information regarding Maple Leaf Green World Inc., please visit www.mlgreenworld.com.
 
About Maple Leaf Green World Inc.
Maple Leaf is a public Canadian company that focuses on the cannabis industry in North America. The Company currently operates 3 cannabis projects in British Columbia, California, and Nevada. With over 10 years of extensive greenhouse management experience, it applies its eco-agriculture knowledge and cultivation technology to produce contaminant-free organic cannabis products. Maple Leaf’s long-term objective is to produce cannabis oil and export its products to approved countries.
 
Cautionary Statement
This press release includes certain statements that may be deemed “forward-looking statements” within the meaning of applicable Canadian securities legislation. Specifically, this press release includes, but is not limited to, forward-looking statements with respect to the review of the Transfer Application and the timing thereof, timing with respect to making any suggested changes from the Staff Panel before the Transfer Application is presented to the Council for approval, the approval of the transfer of the Nevada Permit to Maple Leaf, the construction of the Nevada Site and the timelines thereof, and the anticipated approvals of the Investor Relations Agreement and renewal of the terms thereunder. Generally, forward-looking statements can be identified by the forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “projects”, “intends”, “anticipates”, or “does not anticipate”, or “believes”, or “variations of such words and phrases or state that certain actions, events or results “may”, “can”, “could”, “would”, “might”, or “will” be taken”, “occur” or “be achieved”. Forward-looking statements are subject to known and unknown risks, uncertainties, and other factors that may cause the actual results, level of activity, performance, or achievements of the Company to be materially different from those expressed or implied by such forward-looking statements, including but not limited to: risks related to the development and operation of the Company’s projects, risks associated with general economic conditions, adverse industry events, marketing costs, loss of markets, future legislative and regulatory developments involving medical cannabis, inability to access sufficient capital from internal and external sources and/or inability to access sufficient capital on favourable terms, the medical cannabis industry in Canada and the jurisdictions where the Company operates generally, including Nevada, income tax and regulatory matters, competition, crop failure, currency and interest rate fluctuations, regulatory approvals including approvals from the Council of the Company’s Transfer Application, and those factors discussed in the sections relating to risk factors of our business filed in the Company’s required securities filings on SEDAR. Although the Company has attempted to identify important factors that could cause results to differ materially from those contained in forward-looking statements, there may be other factors that cause results to be materially different from those anticipated, described, estimated, assessed or intended. There can be no assurance that any forward-looking statements will prove accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company does not undertake to update any forward-looking statements that are incorporated by reference herein, except in accordance with applicable securities laws.
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
 
 
For further information, please contact:
Maple Leaf Green World Inc.
Raymond Lai, Chairman, President & CEO
+1(403) 452-4552
+1(403) 452-6900
rlai@mlgreenworld.com www.mlgreenworld.com
 
Big Reach Media, Inc. (Investor Relations)
Dale Shirley
Phone: (780) 632-6963
Mobile: (780) 964-4732
dale@bigreachmedia.com
http://www.bigreachmedia.com/
Click here to connect with Maple Leaf Green World (TSXV:MGW; OTCQB:MGWFF) to receive an Investor Presentation.

Source: www.newswire.ca


The Israeli cannabis market is picking up with a new supply deal from a Canadian producer.

Also this week, new data showed sales of Canadian cannabis edible products may be stalling.

Keep reading... Show less

The Israeli cannabis market is picking up as a Canadian producer announced a new supply deal in the country.

Also this week it was shown the sales of Canadian cannabis edible products may be stalling, according to new data.

Keep reading... Show less

The Portnoy Law Firm advises investors that class action lawsuits have been filed on behalf of investors in the following publicly traded companies. Shareholders interested in taking an active role in these cases have until the deadlines indicated below to petition the court. There is no cost or obligation to you. See below for more information on these cases.

Credit Acceptance Corporation investors (NASDAQ: CACC); December 1, 2020 deadline, click here to join .

Keep reading... Show less
  • On November 19 , the Mexican Senate passed comprehensive adult-use cannabis legalization, moving Mexico towards becoming one of the few countries to legalize cannabis nationally
  • On March 31, 2020 , the Company entered into an agreement with Tecnologico de Monterrey , the leading university in Mexico , to educate physicians across Latin America , in advance of the impending regulations in Mexico
  • To date, close to 550 LatAm physicians have obtained their diploma accrediting completion of Khiron’s medical education program
  • The Company plans to deploy its ZereniaTM medical cannabis clinics and telehealth strategy in Mexico , building on the success of its vertical integration strategy in Colombia
  • Expanding the Zerenia clinic strategy will build on the Company’s Colombia knowledge and proven distribution capabilities, with rapid telehealth service adoption and over 5,600 medical cannabis scripts filled to date
  • Mexico represents one of the largest potential markets for medical cannabis in the world and is anticipated to reach $1.2bn USD by 2028 (Prohibition Partners).
  • Company to release Q3 2020 financials and host webcast on Tuesday, December 1st

Khiron Life Sciences Corp. (“Khiron” or the “Company”) (TSXV: KHRN ), (OTCQX: KHRNF), ( Frankfurt : A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe welcomes the passing of adult-use cannabis legislation by the Mexican Senate, which moves the country closer to a legalized cannabis market, and towards provision for medical cannabis products.  Khiron has had a presence in Mexico since 2018 and has been working with doctors and medical institutions to develop a deep understanding of the market.

Keep reading... Show less

Recap of special management call includes upcoming corporate milestones and details of proposed combination with established beverage manufacturer

Emerging leader in infused cannabis beverages, BevCanna Enterprises Inc. (CSE:BEV, OTCQB:BVNNF, FSE:7BC) (“BevCanna” or the “Company”) is pleased to provide a recorded recap of the special management call held on Tuesday November 24, 2020. The call discussed upcoming corporate milestones and reviewed recent developments at the developer and manufacturer of cannabinoid‐infused beverages and consumer products for in‐house brands and white label clients.

Keep reading... Show less